Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol for Postoperative Cognitive Dysfunction in Aortic Arch Surgery
NCT07816068Phase 4Not yet recruiting
- Sponsor
- Seoul National University Hospital
- Start
- Nov 2026
- Primary completion
- Nov 2027
- Countries
- 1
01
Overview
A Phase 4 trial of remimazolam in Post-operative cognitive dysfunction (POCD), postoperative delirium (POD), sponsored by Seoul National University Hospital. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
Post-operative cognitive dysfunction (POCD)postoperative delirium (POD)
Beyond the preview
Go deeper on NCT07816068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07816068.